Seminars in Hematology
Volume 42, Issue 4 , Pages 196-205 , October 2005

Chromosomal Abnormalities and Molecular Markers in Myeloproliferative Disorders

  • Anthony J. Bench

      Affiliations

    • Haemato-Oncology Diagnostics Service, Department of Haematology, Addenbrooke’s Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK
    • ,
  • Heike L. Pahl

      Affiliations

    • Division of Experimental Anaesthesiology, Center for Clinical Research, University Hospital Freiburg, Freiburg, Germany
    • Corresponding Author InformationAddress correspondence to Professor Dr Heike L. Pahl, Center for Clinical Research, University Hospital Freiburg, Breisacher Str. 66, 79106 Freiburg, Germany

References 

  1. Adamson JW , Fialkow PJ , Murphy S , Prchal JF , Steinmann L . Polycythemia vera (Stem-cell and probable clonal origin of the disease) . N Engl J Med . 1976;295:913–916
  2. Jacobson RJ , Salo A , Fialkow PJ . Agnogenic myeloid metaplasia (A clonal proliferation of hematopoietic stem cells with secondary myelofibrosis) . Blood . 1978;51:189–194
  3. Fialkow PJ , Faguet GB , Jacobson RJ , Vaidya K , Murphy S . Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell . Blood . 1981;58:916–919
  4. Liu E , Jelinek J , Pastore YD , Guan YL , Prchal JF , Prchal JT . Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin . Blood . 2003;101:3294–3301
  5. El Kassar N , Hetet G , Briere J , Grandchamp B . X-chromosome inactivation in healthy females (Incidence of excessive lyonization with age and comparison of assays involving DNA methylation and transcript polymorphisms) . Clin Chem . 1998;44:61–67
  6. Harrison CN , Gale RE , Machin SJ , Linch DC . A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications . Blood . 1999;93:417–424
  7. Tonon L , Bergamaschi G , Dellavecchia C , Rosti V , Lucotti C , Malabarba L , et al.   Unbalanced X-chromosome inactivation in haemopoietic cells from normal women . Br J Haematol . 1998;102:996–1003
  8. Prchal JT , Prchal JF , Belickova M , Chen S , Guan Y , Gartland GL , et al.   Clonal stability of blood cell lineages indicated by X-chromosomal transcriptional polymorphism . J Exp Med . 1996;183:561–567
  9. Gale RE , Wheadon H , Boulos P , Linch DC . Tissue specificity of X-chromosome inactivation patterns . Blood . 1994;83:2899–2905
  10. Asimakopoulos FA , Gilbert JG , Aldred MA , Pearson TC , Green AR . Interstitial deletion constitutes the major mechanism for loss of heterozygosity on chromosome 20q in polycythemia vera . Blood . 1996;88:2690–2698
  11. Mitterbauer G , Winkler K , Gisslinger H , Geissler K , Lechner K , Mannhalter C . Clonality analysis using X-chromosome inactivation at the human androgen receptor gene (Humara). Evaluation of large cohorts of patients with chronic myeloproliferative diseases, secondary neutrophilia, and reactive thrombocytosis . Am J Clin Pathol . 1999;112:93–100
  12. El-Kassar N , Hetet G , Briere J , Grandchamp B . Clonality analysis of hematopoiesis in essential thrombocythemia (Advantages of studying T lymphocytes and platelets) . Blood . 1997;89:128–134
  13. Champion KM , Gilbert JG , Asimakopoulos FA , Hinshelwood S , Green AR . Clonal haemopoiesis in normal elderly women (Implications for the myeloproliferative disorders and myelodysplastic syndromes) . Br J Haematol . 1997;97:920–926
  14. Gale RE , Fielding AK , Harrison CN , Linch DC . Acquired skewing of X-chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic clonal loss with age . Br J Haematol . 1997;98:512–519
  15. Christensen K , Kristiansen M , Hagen-Larsen H , Skytthe A , Bathum L , Jeune B , et al.   X-linked genetic factors regulate hematopoietic stem-cell kinetics in females . Blood . 2000;95:2449–2451
  16. Racchi O , Mangerini R , Rapezzi D , Rolfo M , Gaetani GF , Ferraris AM . X chromosome inactivation patterns in normal females . Blood Cells Mol Dis . 1998;24:439–447
  17. Shih LY , Lin TL , Lai CL , Dunn P , Wu JH , Wang PN , et al.   Predictive values of X-chromosome inactivation patterns and clinicohematologic parameters for vascular complications in female patients with essential thrombocythemia . Blood . 2002;100:1596–1601
  18. Bench AJ , Cross NC , Huntly BJ , Nacheva EP , Green AR . Myeloproliferative disorders . Baillieres Best Pract Clin Haematol . 2001;14:531–551
  19. Swolin B , Weinfeld A , Westin J . A prospective long-term cytogenetic study in polycythemia vera in relation to treatment and clinical course . Blood . 1988;72:386–395
  20. Diez Martin JL , Graham DL , Petitt RM , DeWald GW . Chromosome studies in 104 patients with polycythemia vera . Mayo Clin Proc . 1991;68:287–299
  21. Dupriez B , Morel P , Demory JL , Lai JL , Simon M , Plantier I , et al.   Prognostic factors in agnogenic myeloid metaplasia (A report on 195 cases with a new scoring system) . Blood . 1996;88:1013–1018
  22. Tefferi A , Mesa RA , Schroeder G , Hanson CA , Li CY , Dewald GW . Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia . Br J Haematol . 2001;113:763–771
  23. Strasser-Weippl K , Steurer M , Kees M , Augustin F , Tzankov A , Dirnhofer S , et al.   Chromosome 7 deletions are associated with unfavorable prognosis in myelofibrosis with myeloid metaplasia . Blood . 2005;105:4146
  24. Westwood NB , Gruszka-Westwood AM , Pearson CE , Delord CF , Green AR , Huntly BJ , et al.   The incidences of trisomy 8, trisomy 9 and D20S108 deletion in polycythaemia vera (An analysis of blood granulocytes using interphase fluorescence in situ hybridization) . Br J Haematol . 2000;110:839–846
  25. Najfeld V , Montella L , Scalise A , Fruchtman S . Exploring polycythemia vera with FISH (additional cryptic 9p is the most frequent abnormality detected) . Br J Hematol . 2002;119:1–9
  26. Dewald GW , Schad CR , Lilla VC , Jalal SM . Frequency and photographs of HGM11 chromosome anomalies in bone marrow samples from 3,996 patients with malignant hematologic neoplasms . Cancer Genet Cytogenet . 1993;68:60–69
  27. Bench AJ , Nacheva EP , Hood TL , Holden JL , French L , Swanton S , et al.  UK Cancer Cytogenetics Group (UKCCG)   Chromosome 20 deletions in myeloid malignancies (reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes) . Oncogene . 2000;19:3902–3913
  28. White NJ , Nacheva E , Asimakopoulos FA , Bloxham D , Paul B , Green AR . Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B cells . Blood . 1994;83:2809–2816
  29. Reeder TL , Bailey RJ , Dewald GW , Tefferi A . Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia . Blood . 2003;101:1981–1983
  30. Wang PW , Iannantuoni K , Davis EM , Espinosa R , Stoffel M , Le Beau MM . Refinement of the commonly deleted segment in myeloid leukemias with a del(20q) . Genes Chromosomes Cancer . 1998;21:75–81
  31. Koga H , Matsui S , Hirota T , Takebayashi S , Okumura K , Saya H . A human homolog of Drosophila lethal(3)malignant brain tumor (l(3)mbt) protein associates with condensed mitotic chromosomes . Oncogene . 1999;18:3799–3809
  32. Boccuni P , MacGrogan D , Scandura JM , Nimer SD . The human L(3)MBT polycomb group protein is a transcriptional repressor and interacts physically and functionally with TEL (ETV6) . J Biol Chem . 2003;278:15412–15420
  33. Bench AJ , Li J , Huntly BJ , Delabesse E , Fourouclas N , Hunt AR , et al.   Characterization of the imprinted polycomb gene L3MBTL, a candidate 20q tumour suppressor gene, in patients with myeloid malignancies . Br J Haematol . 2004;127:509–518
  34. MacGrogan D , Kalakonda N , Alvarez S , Scandura JM , Boccuni P , Johansson B , et al.   Structural integrity and expression of the L3MBTL gene in normal and malignant hematopoietic cells . Genes Chromosomes Cancer . 2004;41:203–213
  35. Li J , Bench AJ , Vassiliou GS , Fourouclas N , Ferguson-Smith AC , Green AR . Imprinting of the human L3MBTL gene, a polycomb family member located in a region of chromosome 20 deleted in human myeloid malignancies . Proc Natl Acad Sci U S A . 2004;101:7341–7346
  36. La Starza R , Wlodarska I , Aventin A , Falzetti D , Crescenzi B , Martelli MF , et al.   Molecular delineation of 13q deletion boundaries in 20 patients with myeloid malignancies . Blood . 1998;91:231–237
  37. Calin GA , Dumitru CD , Shimizu M , Bichi R , Zupo S , Noch E , et al.   Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia . Proc Natl Acad Sci U S A . 2002;99:15524–15529
  38. Mertens D , Wolf S , Schroeter P , Schaffner C , Dohner H , Stilgenbauer S , et al.   Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia . Blood . 2002;99:4116–4121
  39. Calin GA , Sevignani C , Dumitru CD , Hyslop T , Noch E , Yendamuri S , et al.   Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers . Proc Natl Acad Sci U S A . 2004;101:2999–3004
  40. Kralovics R , Guan YL , Prchal JT . Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera . Exp Hematol . 2002;30:229–236
  41. Kralovics R , Buser AS , Teo SS , Coers J , Tichelli A , Van Der Maas AP , et al.   Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders . Blood . 2003;102:1869–1871
  42. Kralovics R , Stockton DW , Prchal JT . Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease . Blood . 2003;102:3793–3796
  43. Kralovics R , Passamonti F , Buser AS , Teo SS , Tiedt R , Passweg JR , et al.   A gain-of-function mutation of JAK2 in myeloproliferative disorders . N Engl J Med . 2005;352:1779–1790
  44. Andrieux J , Demory JL , Dupriez B , Quief S , Plantier I , Roumier C , et al.   Dysregulation and overexpression of HMGA2 in myelofibrosis with myeloid metaplasia . Genes Chromosomes Cancer . 2004;39:82–87
  45. Odero MD , Grand FH , Iqbal S , Ross F , Roman JP , Vizmanos JL , et al.   Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies . Leukemia . 2005;19:245–252
  46. Xiao S , McCarthy JG , Aster JC , Fletcher JA . ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain . Blood . 2000;96:699–704
  47. Grand EK , Grand FH , Chase AJ , Ross FM , Corcoran MM , Oscier DG , et al.   Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome . Genes Chromosomes Cancer . 2004;40:78–83
  48. Cools J , DeAngelo DJ , Gotlib J , Stover EH , Legare RD , Cortes J , et al.   A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome . N Engl J Med . 2003;348:1201–1214
  49. Gotlib J , Cools J , Malone JM , Schrier SL , Gilliland DG , Coutre SE . The FIP1L1-PDGFRalpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia (Implications for diagnosis, classification, and management) . Blood . 2004;103:2879–2891
  50. Pardanani A , Tefferi A . Imatinib targets other than bcr/abl and their clinical relevance in myeloid disorders . Blood . 2004;104:1931–1939
  51. Weinberg RS . In vitro erythropoiesis in polycythemia vera and other myeloproliferative disorders . Semin Hematol . 1997;34:64–69
  52. Prchal JT . Pathogenetic mechanisms of polycythemia vera and congenital polycythemic disorders . Semin Hematol . 2001;38:10–20
  53. Prchal JF , Axelrad AA . Bone-marrow responses in polycythemia vera . N Engl J Med . 1974;290:1382
  54. Westwood NB , Pearson TC . Diagnostic applications of haemopoietic progenitor culture techniques in polycythaemias and thrombocythaemias . Leuk Lymphoma . 1996;22:95–103
  55. Prchal JF , Adamson JW , Murphy S , Steinmann L , Fialkow PJ . Polycythemia vera. The in vitro response of normal and abnormal stem cell lines to erythropoietin . J Clin Invest . 1978;61:1044–1047
  56. Kralovics R , Prchal JT . Haematopoietic progenitors and signal transduction in polycythaemia vera and primary thrombocythaemia . Baillieres Clin Haematol . 1998;11:803–818
  57. Dobo I , Mossuz P , Campos L , Girodon F , Allegraud A , Latger-Cannard V , et al.   Comparison of four serum-free, cytokine-free media for analysis of endogenous erythroid colony growth in polycythemia vera and essential thrombocythemia . Hematol J . 2001;2:396–403
  58. Shih L-Y , Lee C-T . Identification of masked polycythemia vera from patients with idiopathic marked thrombocytosis by endogenous erythroid colony assay . Blood . 1994;83:744–748
  59. Griesshammer M , Klippel S , Strunck E , Temerinac S , Mohr U , Heimpel H , et al.   PRV-1 mRNA expression discriminates two types of essential thrombocythemia . Ann Hematol . 2004;83:364–370
  60. Pahl HL . Polycythaemia vera (Will new markers help us answer old questions?) . Acta Haematol . 2002;108:120–131
  61. Correa PN , Eskinazi D , Axelrad AA . Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro (Studies in an improved serum-free medium) . Blood . 1994;83:99–112
  62. Dai C-H , Krantz SB , Means RT , Horn ST , Gilbert HS . Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3 . J Clin Invest . 1991;87:391–396
  63. Dai CH , Krantz SB , Green WF , Gilbert HS . Polycythemia vera III (Burst-forming units-erythroid (BFU-E) response to stem cell factor and c-kit receptor expression) . Br J Haematol . 1994;86:12–21
  64. Horikawa Y , Matsumura I , Hashimoto K , Shiraga M , Kosugi S , Tadokoro S , et al.   Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia . Blood . 1997;90:4031–4038
  65. Moliterno AR , Hankins D , Spivak JL . Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera . N Engl J Med . 1998;338:572–580
  66. Moliterno AR , Spivak JL . Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera . Blood . 1999;94:2555–2561
  67. Moliterno AR , Williams DM , Spivak JL . Enhanced in vitro viability of polycythemia vera CD34+ cells is associated with abnormal thrombopoietin receptor expression and aberrant signal transduction . Blood . 2001;98:469a; (abstr)
  68. Le Blanc K , Andersson P , Samuelsson J . Marked heterogeneity in protein levels and functional integrity of the thrombopoietin receptor c-mpl in polycythaemia vera . Br J Haematol . 2000;108:80–85
  69. Moliterno AR , Silver RT , Spivak JL . A diagnostic assay for polycythemia vera . Blood . 2000;96:512a; (abstr)
  70. Li JZ , Xia YP , Kuter DJ . The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia . Br J Haematol . 2000;111:943–953
  71. Harrison CN , Gale RE , Pezella F , Mire-Sluis A , Machin SJ , Linch DC . Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value . Br J Haematol . 1999;107:139–147
  72. Tefferi A , Yoon SY , Li CY . Immunohistochemical staining for megakaryocyte c-mpl may complement morphologic distinction between polycythemia vera and secondary erythrocytosis . Blood . 2000;96:771–772
  73. Teofili L , Pierconti F , Di Febo A , Maggiano N , Vianelli N , Ascani S , et al.   The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemia . Blood . 2002;100:714–717
  74. Temerinac S , Klippel S , Strunck E , Röder S , Lübbert M , Lange W , et al.   Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera . Blood . 2000;95:2569–2576
  75. Klippel S , Strunck E , Temerinac S , Bench AJ , Meinhardt G , Mohr U , et al.   Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis . Blood . 2003;102:3569–3574
  76. Cilloni D , Carturan S , Gottardi E , Messa F , Fava M , Defilippi I , et al.   Usefulness of the quantitative assessment of PRV-1 gene expression for the diagnosis of polycythemia vera and essential thrombocythemia patients . Blood . 2004;103:2428; (letter)
  77. Florensa L , Besses C , Zamora L , Bellosillo B , Espinet B , Serrano S , et al.   Endogenous erythroid and megakaryocytic circulating progenitors, HUMARA clonality assay, and PRV-1 expression are useful tools for diagnosis of polycythemia vera and essential thrombocythemia . Blood . 2004;103:2427–2428
  78. Klippel S , Pahl HL . Molecular markers for the diagnosis of Philadelphia chromosome negative myeloproliferative disorders . Pathol Biol . 2004;52:267–274
  79. Teofili L , Martini M , Luongo M , DiMario A , Leone G , De Stefano V , et al.   Overexpression of polycythemia rubra vera-1 gene in essential thrombocythemia . J Clin Oncol . 2002;20:4249–4254
  80. Teofili L , Martini M , Guidi F , Venditti D , Leone G , Larocca ML . The PRV-1 gene expression in essential thrombocythemia . Blood . 2004;104:2995–2996
  81. Tefferi A , Lasho TL , Wolanskyj AP , Mesa RA . Neutrophil PRV-1 expression across the chronic myeloproliferative disorders and in secondary or spurious polycythemia . Blood . 2004;103:3547–3548
  82. Passamonti F , Pietra D , Malabarba L , Rumi E , Della Porta MG , Malcovati L , et al.   Clinical significance of neutrophil CD177 mRNA expression in Ph-negative chronic myeloproliferative disorders . Br J Haematol . 2004;126:650–656
  83. Sirhan S , Lasho TL , Elliott MA , Tefferi A . Neutrophil polycythemia rubra vera-1 expression in classic and atypical myeloproliferative disorders and laboratory correlates . Haematologica . 2005;90:406–408
  84. Jelinek J , Jedlickova K , Guan Y , Prchal JT . Instability of PRV-1 mRNA (A factor to be considered in PRV-1 quantification for the diagnosis of polycythemia vera) . Haematologica . 2004;89:749–751
  85. Palmqvist L , Goerttler PS , Wasslavik C , Johansson P , Andreasson B , Safai-Kutti S , et al.   Method Comparison of PRV-1 mRNA quantification in whole blood leukocytes and purified granulocytes . Clin Chem . 2004;50:644–647
  86. Johansson P , Ricksten A , Wennstrom L , Palmqvist L , Kutti J , Andreasson B . Increased risk for vascular complications in PRV-1 positive patients with essential thrombocythaemia . Br J Haematol . 2003;123:513–516
  87. Goerttler PS , Dörner E , Johansson PL , Andreasson B , Kutti J , Moliterno AR , et al.   Thrombotic complications in four subpopulations of patients with ET defined by c-Mpl protein expression and PRV-1 mRNA levels . Haematologica . 2005;90:851–853
  88. Vannucchi AM , Grossi A , Pancrazzi A , Antonioli E , Guglielmelli P , Balestri F , et al.   PRV-1, erythroid colonies and platelet Mpl are unrelated to thrombosis in essential thrombocythaemia . Br J Haematol . 2004;127:214–219
  89. Klippel S , Strunck E , Busse CE , Behringer D , Pahl HL . Biochemical characterization of PRV-1, a novel hematopoietic cell surface receptor, which is overexpressed in polycythemia rubra vera . Blood . 2002;100:2441–2448
  90. Coch C , Bartels K , Buchkremer S , Hublitz P , Pahl H . PRV-1/NB1/CD177 physically interacts with the growth regulatory proteoglycan decorin . Blood . 2002;100:2307a; (abstr)
  91. Mnjoyan Z , Li J , Afshar-Kharghan V . Expression of polycythemia rubra vera-1 decreases the dependency of cells on growth factors for proliferation . Haematologica . 2005;90:405–406
  92. Shaffer AL , Rosenwald A , Hurt EM , Giltnane JM , Lam LT , Pickeral OK , et al.   Signatures of the immune response . Immunity . 2001;15:375–385
  93. Yeoh EJ , Ross ME , Shurtleff SA , Williams WK , Patel D , Mahfouz R , et al.   Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling . Cancer Cell . 2002;1:133–143
  94. Savage KJ , Monti S , Kutok JL , Cattoretti G , Neuberg D , De Leval L , et al.   The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma . Blood . 2003;102:3871–3879
  95. Pellagatti A , Vetrie D , Langford CF , Gama S , Eagleton H , Wainscoat JS , et al.   Gene expression profiling in polycythemia vera using cDNA microarray technology . Cancer Res . 2003;63:3940–3944
  96. Goerttler PS , Kreutz C , Donauer J , Faller D , Maiwald T , Marz E , et al.   Gene expression profiling in polycythaemia vera (overexpression of transcription factor NF-E2) . Br J Haematol . 2005;129:138–150
  97. Tenedini E , Fagioli ME , Vianelli N , Tazzari PL , Ricci F , Tagliafico E , et al.   Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells . Blood . 2004;104:3126–3135
  98. Andrews N , Erdjument-Bromage H , Davidson MB , Tempst P , Orkin SH . Erythroid transcription factor NF-E2 is a hematopoietic-specific basic-leucine zipper protein . Nature . 1993;362:722–728
  99. Toki T , Itoh J , Arai K , Kitazawa J , Yokoyama M , Igarashi K , et al.   Abundant expression of erythroid transcription factor P45 NF-E2 mRNA in human peripheral granurocytes . Biochem Biophys Res Commun . 1996;219:760–765
  100. Sayer MS , Tilbrook PA , Spadaccini A , Ingley E , Sarna MK , Williams JH , et al.   Ectopic expression of transcription factor NF-E2 alters the phenotype of erythroid and monoblastoid cells . J Biol Chem . 2000;275:25292–25298
  101. Eridani S , Sawyer B , Pearson TC . Patterns of in vitro BFU-E proliferation in different forms of polycythaemia and in thrombocythaemia . Eur J Haematol . 1987;38:363–369
  102. Labbaye C , Valtieri M , Barberi T , Meccia E , Masella B , Pelosi E , et al.   Differential expression and functional role of GATA-2, NF-E2, and GATA-1 in normal adult hematopoiesis . J Clin Invest . 1995;95:2346–2358
  103. Baxter EJ , Scott LM , Campbell PJ , East C , Fourouclas N , Swanton S , et al.   Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders . Lancet . 2005;365:1054–1061
  104. James C , Ugo V , Le Couedic JP , Staerk J , Delhommeau F , Lacout C , et al.   A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera . Nature . 2005;27:27
  105. Levine R , Wadleigh M , Cools J , Ebert B , Wernig G , Huntly B , et al.   Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis . Cancer Cell . 2005;7:387–397
  106. Goerttler P , Doerner E , Kutti J , Moliterno AR , Spivak JL , Pahl HL . Quantification of c-Mpl Protein Expression and PRV-1 mRNA levels distinguish four distinct subpopulations of patients with ET . Blood . 2002;100:797a
  107. Goerttler PS , Steimle C , März E , Johansson PL , Andreasson B , Griesshammer M , et al.   The Jak2V617F mutation, PRV-1 overexpression and EEC formation define a similar cohort of MPD patients . Blood . 2005; Jun [Epub ahead of print]
  108. Jones AV , Kreil S , Zoi K , Waghorn K , Curtis C , Zhang L , et al.   Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders . Blood . 2005;26:26
  109. Pahl HL . Molecular markers in myeloproliferative disorders (From classification to prognosis?) . Hematology . 2003;8:199–209

PII: S0037-1963(05)00143-5

doi: 10.1053/j.seminhematol.2005.08.001

Seminars in Hematology
Volume 42, Issue 4 , Pages 196-205 , October 2005

Article Tools

* Image Usage & Resolution